News | Radiation Therapy | August 03, 2016

National Cancer Institute Leader Talks Cancer Moonshot at AAPM

Spoke to medical physicists, who play key role in cancer diagnosis, treatment

NCI, Cancer Moonshot, radiation therapy

Douglas R. Lowy, M.D., acting director of the National Cancer Institute (NCI).

Providing insights into the Cancer Moonshot and other initiatives to accelerate cancer research and make more therapies available to patients, Douglas R. Lowy, M.D., acting director of the National Cancer Institute (NCI), led a plenary session at the 58th Annual Meeting of the American Association of Physicists in Medicine (AAPM).

Medical physicists play a vital role in the diagnosis and treatment of cancer, through the development of novel imaging techniques, advancement of innovative therapy approaches, and ensuring the clinical use of imaging and radiation therapy are safe and effective. The NCI currently is funding several research initiatives on imaging and radiation therapy to better understand how to use immunotherapies in combination with targeted therapies and treatments such as chemotherapy and radiation.

“As medical physicists, we look forward to exploring ways in which our unique skills in the safe and accurate use of technology and radiation can advance the goals of the Cancer Moonshot,” said Bruce H. Curran, M.Eng., M.S., president of AAPM and associate professor of radiation oncology at VCU Health Systems, Richmond, Va. “We play a vital role as professionals involved not only in helping to treat cancer patients, but improving diagnosis and monitoring the response of cancer therapies during treatment.”

A longtime researcher, Lowy is one of the most highly cited authors in microbiology, and a member of the National Academy of Sciences and the Institute of Medicine. He received the 2007 Federal Employee of the Year Award from the Partnership for Public Service, the 2007 Dorothy P. Landon-American Association for Cancer Research Prize for Translational Cancer Research, the Sabin Gold Medal in 2011 and the National Medal of Technology and Innovation from President Obama in 2014, among others.

Lowy’s research focuses on papillomaviruses and the regulation of normal and neoplastic growth. In the 1980s he identified the oncogenes encoded by papillomaviruses and recently worked on papillomavirus vaccines and its life cycle.

For more information:

Related Content

Videos | Radiation Therapy | February 21, 2019
ITN Associate Editor Jeff Zagoudis speaks with Christy Kesslering, M.D., medical director of radiation oncology at th
FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S.
Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor


News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...